Salix falls to loss, CFO resigns
November 07, 2014 at 11:30 AM EST
Salix
Pharmaceuticals Ltd. (Nasdaq: SLXP) fell to a loss for the third quarter of $1.39 per diluted share compared with earnings of 71 cents per diluted share in the year ago period and
announced the resignation of chief financial officer Adam C. Derbyshire.
